# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Vandetanib | 22 | IC50 | = | 20 | nM | ALA5152022 | 7.70 | nM | Homo sapiens | ||
2. | Cabozantinib (XL184, BMS-907351) | CABOZANTINIB | IC50 | = | 34 | nM | ALA5152022 | 7.47 | nM | Homo sapiens | ||
3. | CEP-32496 | 40, CEP-32496 | IC50 | = | 7 | nM | ALA5152022 | 8.15 | nM | Homo sapiens | ||
4. | ALA5171764 | Pralsetinib | IC50 | = | 0.4 | nM | ALA5152022 | 9.40 | nM | Homo sapiens | ||
5. | CEP-32496 | 40, CEP-32496 | IC50 | = | 0.33 | nM | ALA5152012 | 9.48 | nM | Homo sapiens | ||
6. | Lenvatinib (E7080) | E7080 | IC50 | = | 10 | nM | ALA3428924 | 8.00 | nM | Homo sapiens | ||
7. | ALA3906151 | I-8 | INH | = | 100 | % | ALA3868202 | % | Homo sapiens | |||
8. | ALA3906151 | I-8 | INH | = | 100 | % | ALA3868201 | % | Homo sapiens | |||
9. | ALA3906151 | I-8 | INH | 0 | ALA3868200 | Active | % | Homo sapiens | ||||
10. | ALA3906151 | I-8 | INH | 0 | ALA3868199 | Active | % | Homo sapiens | ||||
11. | ALA3906151 | I-8 | INH | = | 100 | % | ALA3868198 | % | Homo sapiens | |||
12. | ALA3906151 | I-8 | INH | 0 | ALA3868197 | Active | % | Homo sapiens | ||||
13. | ALA3906151 | I-8 | IC50 | = | 406.9 | nM | ALA3868195 | 6.39 | nM | Homo sapiens | ||
14. | Ponatinib (AP24534) | 20g, AP24534 | IC50 | = | 180.4 | nM | ALA3868195 | 6.74 | nM | Homo sapiens | ||
15. | Cabozantinib (XL184, BMS-907351) | CABOZANTINIB | IC50 | = | 889 | nM | ALA3831014 | 6.05 | nM | Homo sapiens | ||
16. | ALA3735648 | 15b | IC50 | = | 43.6 | nM | ALA3831014 | 7.36 | nM | Homo sapiens | ||
17. | ALA4790634 | 9x | INH | 0 | ALA4710017 | Active | % | Homo sapiens | ||||
18. | ALA4790634 | 9x | INH | 0 | ALA4710016 | Active | % | Homo sapiens | ||||
19. | ALA4790634 | 9x | INH | 0 | ALA4710015 | Active | % | Homo sapiens | ||||
20. | ALA4790634 | 9x | INH | 0 | ALA4710014 | Active | % | Homo sapiens |